Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial
Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Neurology
Authors: Adam L Boxer, David S Knopman, Daniel I Kaufer, Murray Grossman, Chiadi Onyike, Neill Graf-Radford, Mario Mendez, Diana Kerwin, Alan Lerner, Chuang-Kuo Wu, Mary Koestler, Jill Shapira, Kathryn Sullivan, Kristen Klepac, Kristine Lipowski, Jerin Ullah, Scott Fields, Joel H Kramer, Jennifer Merrilees, John Neuhaus, M Marsel Mesulam, Bruce L Miller
Institutions: University of California, San Francisco, Mayo Clinic, University of North Carolina at Chapel Hill, University of Pennsylvania, Johns Hopkins University, Mayo Clinic in Florida, University of California, Los Angeles, Northwestern University, Case Western Reserve University, Texas Tech University
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Larry L. Hillblom Foundation, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Agouron Institute, TauRx Pharmaceuticals, National Institutes of Health, Genentech, University of California, San Francisco, National Institute on Aging, National Institute on Deafness and Other Communication Disorders, National Center for Advancing Translational Sciences
OpenAlex ID: W2106046611